|
1.00 pm-1.35 pm
Pathology in national programs: A UK overview
Dr Bernie Croal, President, Royal College of Pathologists, United Kingdom
1.35 pm-2.10 pm
Qatar national newborn screening programs
Dr Mamatha Ramaswamy, Senior Consultant in Metabolic Medicine, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Qatar
2.10 pm-2.45 pm
Qatar national programs for infections and antimicrobial stewardship
Dr Emad Ibrahim, Senior Consultant and Microbiology Division Head, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Qatar
|
1.00 pm-1.30 pm
The pathologist’s role in the future of POCT; ensuring quality in a rapid response world
Mrs. Katy Heaney, Consultant Clinical Scientist, Specialty lead Point of Care Testing,
Frimley Health NHS Foundation Trust, Berkshire and Surrey Pathology Services, United Kingdom
(on behalf of the Association for Laboratory Medicine, United Kingdom)
1.30 pm-1:55 pm
Rapid diagnostics in microbiology update
Dr Faiha El-Tayeb. Consultant Microbiologist, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Qatar
1.55 pm-2.20 pm
Rapid diagnostics in Anatomic Pathology update
Dr Rajen Goyal, Senior Consultant in Anatomic Pathology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Qatar
2.20 pm-2.45 pm
Rapid tests in cancer diagnosis update
Dr Amal Aly, Vice Chair of Clinical Pathology and Senior Consultant Diagnostic Genomics Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Qatar
|
1.00 pm-1.35 pm
Precision Medicine diagnostics: an overview from Qatar
Dr Radja Badji,
Translational Genomics Manager,
Qatar Precision Health Institute, Qatar
1.35 pm-2.10 pm
Current trends in genetics
Dr Shakir Bahzad
Geneticist at Kuwait Medical Genetics Center and Head of Pathology Lab at Kuwait Cancer Control Center (Ministry of Health – Kuwait).
2.10 pm-2.45 pm
Current trends in molecular profiling in Anatomic Pathology
Dr Emad Rakha, Senior Consultant in Anatomic Pathology, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Qatar
|
3.15 pm-5.00 pm
|
3.15 pm-3.50 pm Qatar national pre-marital screening program
Dr. Moza Al Kowari, Clinical Scientist, Diagnostic Genomics Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Qatar
3.50 pm-4.25 pm
Pediatric Cellular Therapy Program in Qatar
Dr Chiara Cugno, Director-Advanced Cell Therapy Core, Sidra Medicine, Qatar
4.25 pm-5.00 pm
Qatar National Blood Donation Service
Dr Saloua Al Hmissi
Associate Consultant, Transfusion Medicine, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Qatar
|
3.15 pm-3.45 pm
Ethical, quality and accreditation considerations for point of care testing services
Ms Alyson Bryant Healthcare Accreditation Specialist,
United Kingdom Accreditation Service
3.45 pm-4.10 pm
Point of care testing in trauma and emergency surgeries
Dr Sandro Rizoli, Medical Director of Trauma, Hamad Medical Corporation, Qatar
4.10 pm-4.35 pm Point of care testing in mental health services
Dr Ovais Wadoo, Senior Consultant Psychiatrist, Hamad Medical Corporation, Qatar
4.35 pm-5.00 pm Point of care and rapid tests in virology update
Dr Peter Coyle, Senior Consultant Virologist and Virology Section Head, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Qatar
|
3.15 pm-3.50 pm Current trends in leukemia diagnosis: From phenotype to genotype to …?
Professor Torstan Haferlach, Director, Munich Leukemia Laboratory, Germany
3.50 pm-4.25 pm
Cellular Therapy (transplant and gene therapy) in hemoglobinopathies
Dr Emanuele Angelucci, Hematology and Cellular Therapy Unit Chair
“Alberto Marmont” Transplant and Cellular Therapy Program Chair
IRCCS Ospedale Policlinico San Martino, Genova,
Italy.
4.25 pm-5.00 pm
Update on Diagnostic Genomics Testing- The key Driver of Precision Medicine
Dr. Wafa Abualainin
Consultant Clinical Scientist, Diagnostic Genomics Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Qatar
|